Form 8-K - Current report:
SEC Accession No. 0001564590-20-049411
Filing Date
2020-11-02
Accepted
2020-11-02 06:11:16
Documents
13
Period of Report
2020-10-29
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K qtnt-8k_20201029.htm   iXBRL 8-K 95053
2 EX-10.1 qtnt-ex101_24.htm EX-10.1 150624
  Complete submission text file 0001564590-20-049411.txt   410532

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA qtnt-20201029.xsd EX-101.SCH 5784
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE qtnt-20201029_lab.xml EX-101.LAB 19394
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE qtnt-20201029_pre.xml EX-101.PRE 11612
6 EXTRACTED XBRL INSTANCE DOCUMENT qtnt-8k_20201029_htm.xml XML 3543
Mailing Address 28 ESPLANADE SAINT HELIER Y9 JE2 3QA
Business Address 28 ESPLANADE SAINT HELIER Y9 JE2 3QA 41274832286
Quotient Ltd (Filer) CIK: 0001596946 (see all company filings)

IRS No.: 264719797 | State of Incorp.: Y9 | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-36415 | Film No.: 201278884
SIC: 2835 In Vitro & In Vivo Diagnostic Substances